Literature DB >> 19299309

Risk factors associated with major cerebrovascular complications after intracranial stenting.

F Nahab1, M J Lynn, S E Kasner, M J Alexander, R Klucznik, O O Zaidat, J Chaloupka, H Lutsep, S Barnwell, M Mawad, B Lane, M I Chimowitz.   

Abstract

BACKGROUND: There are limited data on the relationship between patient and site characteristics and clinical outcomes after intracranial stenting.
METHODS: We performed a multivariable analysis that correlated patient and site characteristics with the occurrence of the primary endpoint (any stroke or death within 30 days of stenting or stroke in the territory of the stented artery beyond 30 days) in 160 patients enrolled in this stenting registry. All patients presented with an ischemic stroke, TIA, or other cerebral ischemic event (e.g., vertebrobasilar insufficiency) in the territory of a suspected 50-99% stenosis of a major intracranial artery while on antithrombotic therapy.
RESULTS: Cerebral angiography confirmed that 99% (158/160) of patients had a 50-99% stenosis. In multivariable analysis, the primary endpoint was associated with posterior circulation stenosis (vs anterior circulation) (hazard ratio [HR] 3.4, 95% confidence interval [CI] 1.2-9.3, p = 0.018), stenting at low enrollment sites (< 10 patients each) (vs high enrollment site) (HR 2.8, 95% CI 1.1-7.6, p = 0.038), < or = 10 days from qualifying event to stenting (vs > or = 10 days) (HR 2.7, 95% CI 1.0-7.8, p = 0.058), and stroke as a qualifying event (vs TIA/other) (HR 3.2, 95% CI 0.9-11.2, p = 0.064). There was no significant difference in the primary endpoint based on age, gender, race, or percent stenosis (50-69% vs 70-99%).
CONCLUSIONS: Major cerebrovascular complications after intracranial stenting may be associated with posterior circulation stenosis, low volume sites, stenting soon after a qualifying event, and stroke as the qualifying event. These factors will need to be monitored in future trials of intracranial stenting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299309      PMCID: PMC2837590          DOI: 10.1212/01.wnl.0b013e3181a1863c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  [Complications of stent-assistant angioplasty of symptomatic intracranial artery stenosis].

Authors:  Quan-zhong Zhang; Zhong-rong Miao; Shen-mao Li; Feng-shui Zhu; Yang Hua; Mo-li Wang; Qing-bin Song; Feng Ling
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-08-25

2.  Elective stenting of symptomatic basilar artery stenosis.

Authors:  C R Gomez; V K Misra; M W Liu; V R Wadlington; J B Terry; R Tulyapronchote; M S Campbell
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

3.  Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results.

Authors:  E I Levy; M B Horowitz; C J Koebbe; C C Jungreis; G L Pride; K Dutton; P D Purdy
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

4.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

5.  [Symptomatic intracranial artery stenosis: angiographic classifications and stent-assisted angioplasty].

Authors:  Wei-jian Jiang; Bin Du; Yong-jun Wang; Su-xiang Wang; Gui-hong Wang; Min Jin
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2003-08

6.  Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients.

Authors:  Wei-Jian Jiang; Yong-Jun Wang; Bin Du; Su-Xiang Wang; Gui-Hong Wang; Min Jin; Jian-Ping Dai
Journal:  Stroke       Date:  2004-05-06       Impact factor: 7.914

7.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

8.  [Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis].

Authors:  Jian-min Liu; Bo Hong; Qing-hai Huang; Yi Xu; Wen-yuan Zhao; Long Zhang; Rui Zhao; Xiao-ping Zhou
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2004-02-07

9.  Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience.

Authors:  Richard du Mesnil de Rochemont; Bernd Turowski; Martin Buchkremer; Matthias Sitzer; Friedhelm E Zanella; Joachim Berkefeld
Journal:  Radiology       Date:  2004-04       Impact factor: 11.105

10.  Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis.

Authors:  Elad I Levy; Ricardo A Hanel; Bernard R Bendok; Alan S Boulos; Mary L Hartney; Lee R Guterman; Adnan I Qureshi; L Nelson Hopkins
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

View more
  33 in total

Review 1.  Current diagnosis and management of symptomatic intracranial atherosclerotic disease.

Authors:  Shyam Prabhakaran; Jose G Romano
Journal:  Curr Opin Neurol       Date:  2012-02       Impact factor: 5.710

2.  Editorial - do not throw the baby out with the bathwater….

Authors:  T Krings
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

3.  Stenting for the treatment of high-grade intracranial stenoses.

Authors:  S Lanfranconi; A Bersano; V Branca; E Ballabio; M Isalberti; R Papa; L Candelise
Journal:  J Neurol       Date:  2010-07-04       Impact factor: 4.849

4.  China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.

Authors:  Peng Gao; Zhenwei Zhao; Daming Wang; Jian Wu; Yiling Cai; Tianxiao Li; Wei Wu; Huaizhang Shi; Weiwen He; Fengshui Zhu; Liqun Jiao; Feng Ling
Journal:  Interv Neuroradiol       Date:  2015-05-01       Impact factor: 1.610

5.  Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses : analysis of the INTRASTENT multicentric registry.

Authors:  Wiebke Kurre; Friedhelm Brassel; Roland Brüning; Jan Buhk; Bernd Eckert; Susanna Horner; Michael Knauth; Thomas Liebig; Jana Maskova; Dirk Mucha; Vojtech Sychra; Matthias Sitzer; Michael Sonnberger; Marc Tietke; Johannes Trenkler; Bernd Turowski; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2011-01-11       Impact factor: 2.804

6.  Balloon-expandable stent placement in patients with immediate reocclusion after initial successful thrombolysis of acute middle cerebral arterial obstruction.

Authors:  H K Lee; H S Kwak; G H Chung; S B Hwang
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

7.  Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Zoran Rumboldt; Harry J Cloft; Daniel Gibson; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

Review 8.  Intracranial stenting in atherosclerotic disease-recent results and challenges to face.

Authors:  Wiebke Kurre; René Chapot; Richard du Mesnil de Rochemont; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2010-03-30       Impact factor: 2.804

Review 9.  Stenting in Intracranial Stenosis: Current Controversies and Future Directions.

Authors:  Arindam R Chatterjee; Colin P Derdeyn
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

Review 10.  Diagnosis and Treatment of Intracranial Stenoses.

Authors:  W Reith; J Berkefeld; P Dietrich; J Fiehler; O Jansen
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.